Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Nature Medicine
|
May 14, 2024
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial
Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, et al.
Cancer Science
|
February 6, 2021
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer
Shin Takahashi, Yasuhiro Sakamoto, Tadamichi Denda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2023
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2022
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial
Takayuki Yoshino, Eiji Oki, Toshihiro Misumi, et al.
Scientific Reports
|
March 9, 2026
RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research
Shonosuke Wakayama, Shin Takahashi, Kota Ouchi, et al.
Scientific Reports
|
April 10, 2026
Metabolic and functional pathways of gut microbiota in patients with gastric cancer
Ryo Matoba, Hiroshi Iijima, Yasuhiro Sakamoto, et al.
Journal of Gastrointestinal Oncology
|
May 18, 2023
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201
Shin Takahashi, Kota Ouchi, Yasuhiro Sakamoto, et al.
Cancers
|
February 13, 2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)
Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Nature Medicine
|
May 14, 2024
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial
Kohei Shitara, Yung-Jue Bang, Satoru Iwasa, et al.
Cancer Science
|
February 6, 2021
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer
Shin Takahashi, Yasuhiro Sakamoto, Tadamichi Denda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 8, 2023
Soluble programmed cell death ligand 1 predicts prognosis for gastric cancer patients treated with nivolumab: Blood-based biomarker analysis for the DELIVER trial
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2022
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial
Takayuki Yoshino, Eiji Oki, Toshihiro Misumi, et al.
Scientific Reports
|
March 9, 2026
RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research
Shonosuke Wakayama, Shin Takahashi, Kota Ouchi, et al.
Scientific Reports
|
April 10, 2026
Metabolic and functional pathways of gut microbiota in patients with gastric cancer
Ryo Matoba, Hiroshi Iijima, Yasuhiro Sakamoto, et al.
Journal of Gastrointestinal Oncology
|
May 18, 2023
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201
Shin Takahashi, Kota Ouchi, Yasuhiro Sakamoto, et al.
Cancers
|
February 13, 2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS)
Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa, et al.
Page
of 7